Extracellular vesicles (EVs), particularly exosomes, have emerged as critical vectors for the intercellular propagation of pathological proteins in neurodegenerative diseases. This comparison page examines how exosome/EV-mediated spreading differs across Alzheimer's disease (AD), Parkinson's disease (PD), ALS, frontotemporal dementia (FTD), and Huntington's disease (HD).
| Feature | Alzheimer's Disease | Parkinson's Disease | ALS | FTD | Huntington's Disease |
|---|---|---|---|---|---|
| Primary Pathological Protein | Amyloid-beta, Tau | Alpha-synuclein | TDP-43, SOD1 | TDP-43, Tau | Huntingtin (mHTT) |
| EV Types Involved | Exosomes, microvesicles | Exosomes | Exosomes, microvesicles | Exosomes | Exosomes |
| Seed Protein in EVs | Aβ42, phosphorylated tau | Oligomeric α-syn | TDP-43, SOD1 | TDP-43, pTau | mHTT fragments |
| Evidence Strength | Strong | Very Strong | Moderate | Moderate | Emerging |
| Brain Regions Affected | Hippocampus, cortex | Substantia nigra, cortex | Motor cortex, spinal cord | Frontal/temporal cortex | Striatum, cortex |
| Direction of Spread | Synaptic transmission | Prion-like propagation | Neuroanatomic spread | Network-based | Polyglutamine expansion |
In AD, exosomes play a dual role in both propagating and clearing pathological proteins. Neurons release exosomes containing amyloid-beta peptides, particularly Aβ42, which can spread to connected neurons and seed plaque formation (Yuyama et al., 2015). Exosome-associated tau has been detected in cerebrospinal fluid and may contribute to tau propagation across brain regions (Saman et al., 2012).
Key mechanisms include:
PD shows the strongest evidence for exosome-mediated alpha-synuclein propagation. Multiple studies demonstrate that oligomeric alpha-synuclein is enriched in exosomes and can transfer between neurons, propagating Lewy body pathology (Stuendl et al., 2016; Danzer et al., 2012).
Key mechanisms include:
In ALS, exosomes mediate propagation of TDP-43 and SOD1 aggregates. Research shows TDP-43 can be packaged into exosomes and transferred between cells, potentially contributing to the characteristic spreading of TDP-43 pathology (Feiler et al., 2015). Similarly, SOD1-bearing exosomes have been detected in ALS models and patients (Grad et al., 2014).
Key mechanisms include:
FTD involves exosome-mediated propagation of both TDP-43 and tau proteins. The overlap between FTD and ALS in TDP-43 pathology suggests common exosomal spreading mechanisms (Chen et al., 2020).
Key mechanisms include:
HD represents an emerging area of EV research. While less characterized, evidence suggests mutant huntingtin (mHTT) fragments can be released and taken up by neighboring cells via exosomal and non-exosomal pathways.
Key mechanisms include:
All five diseases show evidence of prion-like propagation via exosomes, where pathological proteins can seed misfolding in recipient cells.
Exosomes can cross the BBB bidirectionally, providing a mechanism for peripheral-to-central and central-to-peripheral propagation.
| Target | Approach | Disease Relevance |
|---|---|---|
| Exosome biogenesis inhibition | Reduce release of pathological proteins | PD, AD, ALS |
| Neutralizing antibodies | Target exosomal pathogenic proteins | PD, AD |
| LRRK2 inhibitors | Modulate exosome release | PD |
| GCase augmentation | Improve lysosomal function | PD (GBA) |
| TGF-β signaling | Modulate microglial EV release | Multiple |
| NCT ID | Focus | Phase | Status |
|---|---|---|---|
| NCT05462145 | Exosome-based biomarkers in PD | Observational | Recruiting |
| NCT05306348 | EV biomarkers in AD | Observational | Recruiting |
| NCT05162634 | Alpha-synuclein seeding assays | Observational | Recruiting |
| Gene | Disease | Function |
|---|---|---|
| SNCA | PD | Alpha-synuclein packaging in EVs |
| LRRK2 | PD | Kinase regulating exosome release |
| GBA | PD | Lysosomal function affecting EV biogenesis |
| MAPT | AD/FTD | Tau phosphorylation and exosomal release |
| TARDBP | ALS/FTD | TDP-43 packaging |
| SOD1 | ALS | SOD1 exosomal transmission |
| C9orf72 | ALS/FTD | Dipeptide repeat protein release |
| GRN | FTD | Progranulin and lysosomal function |
| HTT | HD | Huntingtin aggregation and release |